Data on Promising Chemotherapy for Ovarian Cancer Being Presented Soon
News
DelMar Pharmaceutics and its collaborators at the University of Texas MD Anderson Cancer Center will soon present recent data regarding the activity of the chemotherapy agent VAL-083 in ovarian cancer models, according ... Read more